- Remote Monitored Systems advances core nano-production ventures after raising profile through pandemic
Quick facts: Remote Monitored Systems PLC
Remote Monitored Systems PLC (RMS) is currently focused on the development of a face mask through one of its subsidiaries, Pharm 2 Farm Ltd.
Meanwhile, RMS is also focused on the continued development of its majority interest in GyroMetric Systems Limited, which develops monitoring and safeguarding systems for rotating shafts.
The company’s other subsidiary Cloudveil provides Intelligence Services, Security Risk Management and Management Information Systems.
In addition, the company is implementing an enhanced growth strategy via the appraisal of complementary acquisition or investment opportunities.
17 Aug 2021
(, ) () chairman Antony Legge highlighted that its shareholder base has tripled in the past year, driven by investor interest in the Pham 2 Farm business and its copper-nanoparticle featuring anti-viral masks.
The product was seen as a potential game-changer during the first year of the Covid-19 pandemic though Legge, in a statement ahead of today’s AGM, highlighted that a business can’t be built around the short term demands of a single event.
“Nor does such a narrow focus accurately reflect the underlying value of the intellectual property within the business,” he added.
Legge noted that since the start of the year the priority was mask production business where, he said, expectations had run ahead of what was deliverable. Since then attention has returned to the core business of developing innovative solutions using the company’s patented nano-production capability.
23 Jul 2021
(, ) () said marketing of the Pro-Larva face mask improved thanks to the additional support provided to distribution partners in the UK, Europe and India.
In a trading update, the company added the Pro-Larva brand was successfully trademarked in the UK, which it said should assist with the sales efforts of partner Francis MacIntyre Limited (FML) and potentially lead to further orders following FML’s initial 100,000 unit contract announced in March.
25 Jun 2021
() revealed the five-ply version of its Pro-Larva anti-viral mask has been approved by the UK’s Medicines and Healthcare Products Regulatory Agency.
The mask, developed in collaboration with Volz Filters, has an additional filter layer after the hydrophobic outer layer, further strengthening the mask’s bacterial filter efficiency, Remote Monitored Systems (RMS) said.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…
12 hours, 35 minutes ago
3 weeks, 4 days ago
FTSE 100 opened in the green ahead of the Bank of England rates decision and expected changes to the UK’s travel restrictions. London’s leading index added 17 points to 7,091 in early trading.
All eyes will be on the greenlist today with UK ministers expected to announce more countries will…
9 hours, 41 minutes ago
1 day, 9 hours ago
5 days, 8 hours ago
8 hours ago
8 hours, 2 minutes ago
11 hours, 28 minutes ago
11 hours, 33 minutes ago
13 hours, 33 minutes ago
3 weeks, 1 day ago
3 weeks, 1 day ago